Drug treatment of neurocysticercosis

National Medical Journal of India

Volumn 10, Issue 4, 1997, Pages 173-177

  Garg, R K ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; CORTICOSTEROID; FLUBENDAZOLE; METRIFONATE; PRAZIQUANTEL;

BIOTRANSFORMATION; BRAIN CYSTICERCOSIS; CENTRAL NERVOUS SYSTEM INFECTION; DRUG EFFICACY; EPILEPSY; GRANULOMA; HOST RESISTANCE; HUMAN; NEUROCYSTICERCOSIS; ORAL DRUG ADMINISTRATION; REVIEW;

ADRENAL CORTEX HORMONES; ALBENDAZOLE; ANTHELMINTICS; ANTIPLATYHELMINTIC AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; CYSTICERCOSIS; DRUG INTERACTIONS; HUMANS; PRAZIQUANTEL;

EID: 0030796296     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. King CH, Mahmoud AAF. Drugs five years later: Praziquantel. Ann Intern Med 1989;110:290-6.
2. Webbe G. Human cysticercosis: Parasitology, pathology, clinical manifestations and available treatment. Pharmacol Ther 1994;64:175-200.
3. van Den Bossche H. Mode of action of anticestodal agents. In: Campbell WC, Rew RS (eds). Chemotherapy of parasitic diseases. New York:Plenum Press, 1986: 493-501.
4. Cruz I, Cruz ME, Carrasco F, Horton J. Neurocysticercosis: Optimal dose treatment with albendazole. J Neurol Sci 1995;133:152-4.
5. Robles C, Chavarria M. Presentacion de un caso clinico de cisticercosis cerebral curado medicamente con un nuevo farmaco: Praziquantel. Salud Pub Mex 1979; 21:603-18.
6. Botero D, Castano S. Treatment of cysticercosis with praziquantel in Columbia. Am J Trop Med Hyg 1982;31:811-21.
7. Robles C, Sedano AM, Vargas-Tentori N, Galindo-Virgen S. Long term results of praziquantel therapy in neurocysticercosis. J Neurosurg 1987;66:359-63.
8. Groll EW. Chemotherapy of human cysticercosis with praziquantel. In: Flisser A, Willms K, Laclette JP (eds). Cysticercosis: Present state of knowledge and perspectives. New York:Academic Press, 1982:207-18.
9. Sotelo J, Escobedo F, Rodriguez-Carbajal J, Torres B, Rubio-Donnadieu F. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 1984;310: 1001-7.
10. Corona T, Lugo R, Medina R, Sotelo J. Single day praziquantel therapy for neurocysticercosis. N Engl J Med 1996;334:125.
11. Kalra V, Deorari AK, Goulatia RK. Praziquantel therapy in childhood neurocysticercosis. N Engl J Med 1987;20:1095-8.
12. Singhal BS, Sowani AM. Praziquantel in neurocysticercosis. J Assoc Physicians India 1985;35:601-3.
13. Srivastava VK, Singhal KC, Srivastava A, Agrawal A. Praziquantel therapy in neurocysticercosis. Indian J Physiol Pharmacol 1993;37:194-8.
14. Sancheti PC, Dhamija RM, Roy AK, Jena A, Venkataraman S, Krishanan R. Praziquantel therapy in neurocysticercosis. Neurology India 1990;38:139-46.
15. Escobedo F, Penagos P, Rodriguez J, Sotelo J. Albendazole therapy for neurocysticercosis. Arch Intern Med 1987;147:738-41.
16. Cohen L, Belec L, Sanson M, Pierrot-Deseilligny C, Signoret JL. Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis. Rev Neurol Paris 1992;148:58-61.
17. Takayanagui OM, Jardim E. Therapy for neurocysticercosis: Comparison between albendazole and praziquantel. Arch Neurol 1992;49:290-4.
18. del Brutto OH, Sotelo J. Albendazole therapy for subarachnoid and ventricular cysticercosis: Case report. J Neurosurg 1990;72:816-17.
19. del Brutto OH, Sotelo J, Aguirre R, Diaz-Calderon E, Alarcon TA. Albendazole therapy for giant subarachnoid cysticerci. Arch Neurol 1992;49:535-8.
20. Barinagarrementeria F, del Brutto OH. Lacunar syndrome due to neurocysticercosis. Arch Neurol 1989;46:415-17.
21. Levy AS, Lillehei KO, Rubinstein D, Stears JC. Subarachnoid neurocysticercosis with occlusion of the major intracranial arteries: Case report. Neurosurgery 1995; 36:183-8.
22. Martinez HR, Rangel-Guerra R, Arredondo-Estrada JH, Marfil A, Onofre J. Medical and surgical treatment in neurocysticercosis - A magnetic resonance study of 161 cases. J Neurol Sci 1995;130:25-34.
23. del Brutto OH. The use of albendazole in patients with single lesions enhanced on contrast CT. N Engl J Med 1993;328:356-7.
24. del Brutto OH. Single parenchymal brain cysticercus in the acute encephalitic phase: Definition of a distinct form of neurocysticercosis with a benign prognosis. J Neurol Neurosurg Psychiatry 1995;58:247-9.
25. Rajshekhar V. Albendazole therapy for persistent solitary cysticercus granulomas in patients with seizures. Neurology 1993;43:1238-40.
26. Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in single CT ring lesions in epilepsy. Neurology 1994;44:1344-6.
27. Chopra JS, Sawhney IMS, Suresh N, Prabhakar S, Dhand UK, Suri S. Vanishing CT lesions in epilepsy. J Neurol Sci 1992;107:40-9.
28. Srinivas HV. Disappearing CT lesions - Clinical features. J Trop Geograph Neurol 1992;2:88-91.
29. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: A new classification based on active and inactive forms. A study of 753 cases. Arch Intern Med 1985;145: 442-5.
30. del Brutto OH, Sotelo J. Neurocysticercosis: An update. Rev Infect Dis 1988;10: 1075-87.
31. Garg RK. Is medical treatment of neurocysticercosis effective? Natl Med J India 1995;8:269-70.
32. Carpio A, Santillan F, Leon P, Flores C, Hauser WA. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 1995; 155:1982-8.
33. Mitchell WG, Crawford TO. Intraparenchymal cerebral cysticercosis in children: Diagnosis and treatment. Pediatrics 1988;82:76-82.
34. Kramer LD, Locke GE, Byrd SE, Darybagi J. Cerebral cysticercosis: Documentation of natural history with CT. Radiology 1989;171:459-62.
35. Chong MS, Hawkins CP, Cook GC, Hawkes CH, Kocen RS. A resistant case of neurocysticercosis. Postgrad Med J 1991;6:577-8.
36. Garg RK, Kar AM, Jain S. Failure of albendazole therapy in two common types of parenchymal neurocysticercosis. J Assoc Physicians India 1995;43:706-7.
37. Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in neurocysticercosis. Natl Med J India 1995;8:255-8.
38. Commission on Tropical Diseases of the International League Against Epilepsy: Relationship between epilepsy and tropical disease. Epilepsia 1994;35:89-93.
39. del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: Analysis of 203 patients. Neurology 1992;42:389-92.
40. Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696-701.
41. del Brutto OH. Prognostic factors for seizure recurrence after withdrawal of anti-epileptic drugs in patients with neurocysticercosis. Neurology 1994;44:1706-9.
42. Carpio A, Placencia M, Santillan F, Escobar A. A proposal for classification of neurocysticercosis. Can J Neurol Sci 1994;21:43-7.
43. Flisser A, Madrazo I, Plancarte A, Schantz P, Allan J, Craig P, et al. Neurological symptoms in occult neurocysticercosis after single taenicidal dose of praziquantel. Lancet 1993;342:748.
44. Verma A, Pauranik A, Maheshwari MC. Adverse reactions during treatment of neurocysticercosis with praziquantel. Neurol India 1987;35:344-52.
45. Wadia N, Desai S, Bhatt M. Disseminated cysticercosis: New observations, including CT scan findings and experience with treatment by praziquantel. Brain 1988;111:597-614.
46. Markwalder K, Hess K, Valavanis A, Witassek F. Cerebral cysticercosis: Treatment with praziquantel. Report of two cases. Am J Trop Med Hyg 1984;23:273-80.
47. Suastegui Roman RA, Soto-Hernandez JL, Sotelo J. Effects of prednisolone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: A preliminary study. J Neurosurg 1996;84:629-33.
48. Bittencourt PR, Cracia CM, Martins R, Fernandes AG, Diekmann HW, Jung W. Phenytoin and carbamazepine decreased oral bioavailability of praziquantel. Neurology 1992;42:492-6.
49. Vasquez ML, Jung H, Sotelo J. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology 1987;37:1561-2.
50. Shandera WX, White AC, Chen JC, Diaz P, Armstrong R. Neurocysticercosis in Houston, Texas: A report of 112 cases. Medicine 1994;73:37-52.
51. Dachman WD, Adubofour KO, Bikin DS, Johnson CH, Mullin PD, Winograd M. Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. J Infect Dis 1994;169:689-91.
52. Garg RK, Agrawal A. Anticysticercal treatment in case of neurocysticercosis: Is it safe? It is useful? In: Sinha KK, Chandra P (eds). Advances in clinical neurosciences. Ranchi:East Zone Neuro CME, 1994:444-53.
53. Kramer LD. Medical treatment of cysticercosis - ineffective. Arch Neurol 1995; 52:101-2.
54. del Brutto OH. Medical treatment of cysticercosis - effective. Arch Neurol 1995; 52:102-4.
55. Garcia HH, Gilman RH. Medical treatment of cysticercosis: Ineffective vs. effective. Arch Neurol 1995;52:94-101.
56. Salinas R, Garner P. Neurocysticercosis. Arch Neurol 1996;53:213-14.